Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs.

Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M; AIDS Working Group of Médecins Sans Frontières.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):311-8. doi: 10.1097/QAI.0b013e318218a713.

PMID:
21423023
[PubMed - indexed for MEDLINE]
2.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
[PubMed - indexed for MEDLINE]
3.
4.

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A; AIDS Working Group of MSF.

JAMA. 2010 Jul 21;304(3):303-12. doi: 10.1001/jama.2010.980.

PMID:
20639564
[PubMed - indexed for MEDLINE]
5.

Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.

Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1338-47. doi: 10.1089/aid.2006.0308.

PMID:
18184075
[PubMed - indexed for MEDLINE]
6.

Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.

Bwire R, Nagelkerke NJ, Borgdorff MW.

Trop Med Int Health. 2006 Oct;11(10):1567-75.

PMID:
17002731
[PubMed - indexed for MEDLINE]
Free Article
7.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.

PLoS One. 2010 May 7;5(5):e10527. doi: 10.1371/journal.pone.0010527.

PMID:
20479873
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, Doro Altan A, Zimba Ida V, San Lio MM, De Luca A; DREAM Program.

Clin Infect Dis. 2009 Jan 1;48(1):115-122.

PMID:
20380075
[PubMed - indexed for MEDLINE]
Free Article
9.

The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting.

Houben RM, Glynn JR, Mboma S, Mzemba T, Mwaungulu NJ, Mwaungulu L, Mwenibabu M, Mpunga J, French N, Crampin AC.

AIDS. 2012 Nov 13;26(17):2233-9. doi: 10.1097/QAD.0b013e32835958ed.

PMID:
22951633
[PubMed - indexed for MEDLINE]
10.

Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8. doi: 10.1097/QAI.0b013e31824206c7.

PMID:
22134144
[PubMed - indexed for MEDLINE]
11.

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.

AIDS. 2007 Nov 30;21(18):2483-91.

PMID:
18025885
[PubMed - indexed for MEDLINE]
12.

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.

Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

Clin Infect Dis. 2007 Jan 1;44(1):94-102. Epub 2006 Nov 28.

PMID:
17143823
[PubMed - indexed for MEDLINE]
Free Article
13.

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.

Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G; Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).

AIDS. 2000 Sep 8;14(13):1985-91.

PMID:
10997404
[PubMed - indexed for MEDLINE]
14.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

PMID:
23100567
[PubMed - indexed for MEDLINE]
Free Article
15.

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.

Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, Rutherford G, Mermin J.

AIDS. 2007 Mar 30;21(6):713-9.

PMID:
17413692
[PubMed - indexed for MEDLINE]
16.

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, Gill MJ, Dabis F, Reiss P, Kirk O, Bernasconi E, Grabar S, Justice A, Staszewski S, Fätkenheuer G, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

Clin Infect Dis. 2005 Dec 15;41(12):1772-82. Epub 2005 Nov 11.

PMID:
16288403
[PubMed - indexed for MEDLINE]
Free Article
17.

Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.

Van Rie A, Westreich D, Sanne I.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):349-55. doi: 10.1097/QAI.0b013e3181f9fb39.

PMID:
20926954
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Adults receiving HIV care before the start of antiretroviral therapy in sub-Saharan Africa: patient outcomes and associated risk factors.

Bastard M, Nicolay N, Szumilin E, Balkan S, Poulet E, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):455-63. doi: 10.1097/QAI.0b013e3182a61e8d.

PMID:
23892242
[PubMed - indexed for MEDLINE]
19.

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A.

JAMA. 1999 Dec 15;282(23):2220-6.

PMID:
10605973
[PubMed - indexed for MEDLINE]
20.

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, Dabis F, Pascoe M, Egger M; International Epidemiological Databases to Evaluate AIDS (IeDEA).

PLoS Med. 2009 Apr 28;6(4):e1000066. doi: 10.1371/journal.pmed.1000066. Epub 2009 Apr 28.

PMID:
19399157
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk